美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

ASTRAZENECA PLC ADRhedged

53.28

0.0000

成交量：- -

成交额：- -

市值：159.83万

市盈率：- -

高：53.28

开：53.28

低：53.28

收：53.28

52周最高：56.90

52周最低：49.87

股本：3.00万

流通股本：1.00万

量比：2.68

换手率：- -

股息：0.58

股息率：1.08%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

石药集团称与阿斯利康就开发SIRNA药物订立合作、选择权及授权协议。

创新药企携手阿斯利康再达重磅国际合作！全市场仅有的恒生创新药ETF华泰柏瑞连续9个交易日成交额突破10亿

港股异动 | 和誉-B(02256)涨超5% 附属与阿斯利康共同推进一项新型靶免联合疗法治疗NSCLC临床研究

和誉在港交所公告，公司之附属公司和誉医药宣布，与阿斯利康签署战略合作协议，共同推进一项新型靶免联合疗法治疗非小细胞肺癌的

和誉-B(02256)附属与阿斯利康达成战略合作开展同类首创口服PD-L1抑制剂ABSK043联合泰瑞沙®治疗非小细胞肺癌的临床研究

阿斯利康(AZN)股票7月1日盘中下跌3.02%：释放什么信号？

TradingKey中文

携手共建产业创新生态 ——访阿斯利康中国总经理林骁

阿斯利康(AZN)与第一三共重磅新药获欧盟CHMP推荐批准拟用于三阴性乳腺癌成年患者治疗

辉瑞等制药巨头复制“英国剧本”：以撤资施压德国，倒逼欧洲放宽药价管控

数据简报-全球制药企业斥资数十亿美元以扩大在美国的市场份额

重返肿瘤核心战场葛兰素史克(GSK.US)能否借Nuvalent缩小与阿斯利康差距？

智通财经网

阿斯利康加入减肥药赛道：口服药减重11.8%

华尔街见闻

阿斯利康GLP-1口服药在糖尿病与肥胖症试验中通过早期考验

数据简报-邦迪布吉奥埃博拉：疫苗与疗法研发一览

阿斯利康(AZN)股票6月1日收盘下跌3.17%：关键驱动因素揭晓

TradingKey中文

数据简报-正在研发哪些邦迪布吉奥型埃博拉疫苗和治疗方法

阿斯利康(AZN.US)本瑞利珠单抗新适应症获批上市

石药集团(01093)：收到阿斯利康就创新长效多肽药物开发的战略合作与授权协议项下的12亿美元首付款

阿斯利康来无锡深化对接合作

数据简报-邦迪布吉奥埃博拉疫苗和治疗方法正在研发

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/AZNH/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1791835200000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"停牌","change":0,"latestTime":"10-13 05:53:25 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791898200000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":2.6812474453400963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.6812474453400963,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":49.87,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648508319","title":"石药集团称与阿斯利康就开发SIRNA药物订立合作、 选择权及授权协议。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648508319","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648508319?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 16:32","pubTimestamp":1782981130,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2417539215.USD","LU2237443622.USD","LU0058720904.USD","LU0029864427.USD","LU2462157665.USD","IE00B3T34201.USD","LU0432979614.USD","LU2237443895.HKD","BK4588","LU2237443465.HKD","LU0128525929.USD","LU2236285917.USD","LU2468319806.SGD","LU0109394709.USD","LU2456880835.USD","AZNH","LU1267930573.SGD","LU2237443549.SGD","BK4585","LU2237443978.SGD","LU2089984988.USD","BK4568","LU0708994859.HKD","LU1829250122.USD","AZN","LU0310800379.SGD","LU0889565916.HKD","LU2237443382.USD","BK4007","LU0320765992.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648579477","title":"创新药企携手阿斯利康再达重磅国际合作！全市场仅有的恒生创新药ETF华泰柏瑞连续9个交易日成交额突破10亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2648579477","media":"新浪基金","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648579477?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 13:17","pubTimestamp":1782969420,"startTime":"0","endTime":"0","summary":"某港股龙头药企发布公告，旗下子公司与阿斯利康达成战略合作，双方将携手开展新型靶免联合疗法用于非小细胞肺癌的临床试验，这一合作再度引发市场对国产创新药板块的关注。　　目前市场上仅有的跟踪恒生创新药指数的ETF——恒生创新药ETF华泰柏瑞交投热度居高不下，产品已连续9个交易日单日成交额突破10亿元，本周一更是达27.64亿元，创下今年4月3日之后阶段新高，最新规模24.48亿元，场内流动性表现较亮眼。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-07-02/doc-inifkuqa2716838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AZN","BK4588","LU2237443382.USD","LU2468319806.SGD","LU2237443895.HKD","LU0708994859.HKD","LU2237443549.SGD","AZNH","06978","BK1574","LU0320765992.SGD","BK4007","LU2089984988.USD","LU2237443465.HKD","LU2456880835.USD","LU2236285917.USD","LU0058720904.USD","BK4585","LU1829250122.USD","BK1161","LU0889565916.HKD","LU1267930573.SGD","BK4568","159992","LU0432979614.USD","LU2237443978.SGD","520500","LU2237443622.USD","LU0109394709.USD","LU2462157665.USD","LU0289739699.SGD","LU2417539215.USD","LU0128525929.USD","LU0310800379.SGD","LU0029864427.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648357688","title":"港股异动 | 和誉-B(02256)涨超5% 附属与阿斯利康共同推进一项新型靶免联合疗法治疗NSCLC临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2648357688","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648357688?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 11:32","pubTimestamp":1782963123,"startTime":"0","endTime":"0","summary":"消息面上，7月2日，和誉-B发布公告，本公司的附属公司上海和誉生物医药科技有限公司宣布，与阿斯利康签署战略合作协议，共同推进一项新型靶免联合疗法治疗非小细胞肺癌的临床研究。该研究的新药临床试验申请已于2026年5月20日获得国家药品监督管理局批准，本项II期研究由和誉医药主导，和誉医药和阿斯利康将共同承担该临床试验的相关职责。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462181.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AZN","LU0320765992.SGD","LU2488822045.USD","BK4568","LU0109394709.USD","LU2476274720.SGD","LU0889565916.HKD","LU2237443895.HKD","LU0128525929.USD","BK4007","LU2236285917.USD","LU0029864427.USD","LU2468319806.SGD","LU2089984988.USD","BK1161","LU0058720904.USD","IE00B5MMRT66.SGD","LU2237443465.HKD","IE00BPRC5H50.USD","LU2237443549.SGD","AZNH","BK4588","LU2237443978.SGD","02256","LU0289739699.SGD","LU2417539215.USD","LU2476274308.USD","LU2456880835.USD","LU2237443622.USD","VXUS","LU2778985437.USD","LU0432979614.USD","BK4585","LU1267930573.SGD","LU1829250122.USD","LU2462157665.USD","IE00B543WZ88.USD","LU2237443382.USD","IE00B3T34201.USD","LU0310800379.SGD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648152730","title":"和誉在港交所公告，公司之附属公司和誉医药宣布，与阿斯利康签署战略合作协议，共同推进一项新型靶免联合疗法治疗非小细胞肺癌的","url":"https://stock-news.laohu8.com/highlight/detail?id=2648152730","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648152730?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 08:16","pubTimestamp":1782951413,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0029864427.USD","LU2456880835.USD","BK4585","LU2237443465.HKD","LU0058720904.USD","LU2468319806.SGD","LU0109394709.USD","LU2237443549.SGD","LU2089984988.USD","LU0310800379.SGD","LU1829250122.USD","BK4588","LU0889565916.HKD","AZNH","AZN","LU0708994859.HKD","LU0289739699.SGD","LU2236285917.USD","BK4007","LU2462157665.USD","LU2237443978.SGD","LU0320765992.SGD","LU0432979614.USD","LU1267930573.SGD","BK4568","IE00B3T34201.USD","LU2237443622.USD","LU2237443895.HKD","LU0128525929.USD","LU2237443382.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648220025","title":"和誉-B(02256)附属与阿斯利康达成战略合作开展同类首创口服PD-L1抑制剂ABSK043联合泰瑞沙®治疗非小细胞肺癌的临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2648220025","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648220025?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 08:06","pubTimestamp":1782950774,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B 发布公告，本公司的附属公司上海和誉生物医药科技有限公司宣布，与阿斯利康签署战略合作协议，共同推进一项新型靶免联合疗法治疗非小细胞肺癌的临床研究。该联合研究是一项多中心、开放的I/II期临床试验，旨在评估和誉医药自主研发的同类首创口服小分子PD-L1抑制剂 ABSK043联合阿斯利康第三代EGFR-TKI泰瑞沙 ，用于治疗EGFR突变合并PD-L1阳性的局部晚期或转移性NSCLC患者中的安全性和疗效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AZNH","LU0889565916.HKD","BK4568","BK4023","LU2468319806.SGD","LU2236285917.USD","LU0029864427.USD","IE00B543WZ88.USD","LU2778985437.USD","LU2456880835.USD","LU1169590202.USD","IE00BPRC5H50.USD","LU2476274308.USD","LU2089984988.USD","AZN","PD","LU1829250122.USD","LU2237443978.SGD","BK4588","LU2237443382.USD","LU0320765992.SGD","LU2237443622.USD","BK4585","LU0432979614.USD","LU2237443549.SGD","LU2476274720.SGD","LU0109394709.USD","LU0128525929.USD","LU0708994859.HKD","LU2237443465.HKD","IE00B5MMRT66.SGD","LU0310800379.SGD","LU2488822045.USD","BK4007","LU0058720904.USD","LU0289739699.SGD","LU2237443895.HKD","LU1267930573.SGD","BK1161","IE00B3T34201.USD","LU1169589451.USD","02256","LU2462157665.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648540101","title":"阿斯利康(AZN)股票7月1日盘中下跌3.02%：释放什么信号？","url":"https://stock-news.laohu8.com/highlight/detail?id=2648540101","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648540101?lang=zh_cn&edition=fundamental","pubTime":"2026-07-02 01:15","pubTimestamp":1782926138,"startTime":"0","endTime":"0","summary":"• 实验性疗法的临床试验失败和监管延迟给AstraZeneca的股价带来了压力。\n• 市场广泛轮动至周期性板块，正导致资金从防御性医药股中流出。\n• 用于药物研发的新兴人工智能（AI）平台正在促使投资者重新评估传统制药企业的估值。","market":"sg","thumbnail":"https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262004779-market-movers-azn-20260701","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0109394709.USD","LU2237443622.USD","LU2236285917.USD","BK4585","LU0029864427.USD","LU2237443465.HKD","LU0320765992.SGD","AZNH","IE00B3T34201.USD","BK4568","LU1829250122.USD","LU2237443549.SGD","BK4588","LU0432979614.USD","LU2468319806.SGD","LU2456880835.USD","LU2462157665.USD","LU0310800379.SGD","LU2089984988.USD","LU2417539215.USD","AZN","LU2237443978.SGD","LU1267930573.SGD","LU0708994859.HKD","LU0289739699.SGD","LU2237443382.USD","BK4007","LU0889565916.HKD","LU0128525929.USD","LU2237443895.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647003353","title":"携手共建产业创新生态 ——访阿斯利康中国总经理林骁","url":"https://stock-news.laohu8.com/highlight/detail?id=2647003353","media":"经济日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647003353?lang=zh_cn&edition=fundamental","pubTime":"2026-06-30 06:05","pubTimestamp":1782770747,"startTime":"0","endTime":"0","summary":"“中国‘十五五’规划释放了清晰信号，将坚定推进高水平对外开放，中国生物医药产业将迎来全新发展机遇，为跨国药企深耕中国市场筑牢坚实基础。”阿斯利康中国总经理林骁近期在第七届跨国公司领导人青岛峰会期间接受经济日报记者采访时说。今年1月，阿斯利康宣布到2030年在华投资超1000亿元人民币，全面深化在研发、生产、商业化、生态合作的全价值链布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606303787106392.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606303787106392.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LU2237443622.USD","LU2237443382.USD","LU2417539215.USD","AZN","LU0889565916.HKD","LU0320765992.SGD","LU0029864427.USD","LU0310800379.SGD","LU0128525929.USD","LU2462157665.USD","LU0289739699.SGD","LU0432979614.USD","BK4568","BK4007","LU0708994859.HKD","LU2237443549.SGD","LU2237443895.HKD","IE00B3T34201.USD","LU2237443978.SGD","LU2236285917.USD","LU2237443465.HKD","LU1267930573.SGD","LU0109394709.USD","AZNH","BK4588","LU1829250122.USD","LU0058720904.USD","LU2456880835.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646354848","title":"阿斯利康(AZN)与第一三共重磅新药获欧盟CHMP推荐批准 拟用于三阴性乳腺癌成年患者治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2646354848","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646354848?lang=zh_cn&edition=fundamental","pubTime":"2026-06-26 19:17","pubTimestamp":1782472640,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药巨头阿斯利康 与日本第一三共联合开发的新一代抗癌药物 Datroway获欧洲药品管理局下属的人用药品委员会推荐批准作为单药一线疗法，用于治疗不适合接受 PD-1/PD-L1 抑制剂的不可切除或转移性三阴性乳腺癌成年患者。CHMP 的积极推荐主要基于 TROPION-Breast02 第三期全球临床试验的压倒性数据。业内分析认为，该管线的顺利推进将进一步夯实阿斯利康与第一三共在全球 ADC 药物赛道的霸主地位，并为两家公司未来的营收增长注入强劲的确定性。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301958","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","LU0889565916.HKD","LU2417539215.USD","LU0289739699.SGD","AZN","BK4087","BK4588","LU0109394709.USD","BK4568","AZNH","LU2237443549.SGD","LU0708994859.HKD","BK4585","CHMP","LU2456880835.USD","LU0128525929.USD","LU1267930573.SGD","LU0310800379.SGD","LU1829250122.USD","FESXmain","LU2237443978.SGD","IE00B3T34201.USD","LU2237443465.HKD","LU2462157665.USD","LU2237443622.USD","LU2237443895.HKD","FSXEmain","LU0058720904.USD","LU0432979614.USD","BK4007","LU0320765992.SGD","LU2237443382.USD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644435217","title":"辉瑞等制药巨头复制“英国剧本”：以撤资施压德国，倒逼欧洲放宽药价管控","url":"https://stock-news.laohu8.com/highlight/detail?id=2644435217","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644435217?lang=zh_cn&edition=fundamental","pubTime":"2026-06-17 20:32","pubTimestamp":1781699555,"startTime":"0","endTime":"0","summary":"智通财经APP注意到，面对欧洲各国首都对药品定价的抵制，全球制药公司正在搬出近期在英国取得成功的“老剧本”：以撤回投资和扩张计划为威胁，向政策制定者施压。最新的目标是德国，该国目前正在辩论一项旨在收紧药品支出的立法。辉瑞上周致信德国总理，警告称由于该国目前的药品定价政策，其在德国的投资正面临风险；而阿斯利康则警告称，如果这些变革付诸实施，它可能不会在德国推出新药。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455695.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0002141913.USD","LU1057294990.SGD","SG9999002232.USD","LU0133085943.USD","LU1291159041.SGD","SGXZ51526630.SGD","LU1551013425.SGD","LU0943347566.SGD","ELIS","LU1983299246.USD","LU2471134879.HKD","LU2168564065.EUR","LU0114720955.EUR","LU0203201768.USD","IE00BLSP4239.USD","LU0203202063.USD","LU1868836757.USD","LU0256863902.USD","IE00B19Z3B42.SGD","LU2237443549.SGD","LU2237443978.SGD","LU2361044865.SGD","SG9999015952.SGD","LU0320765059.SGD","LU2023250330.USD","LU0238689110.USD","LU2324357040.USD","LU1989771016.USD","LU2237443465.HKD","LU0823434740.USD","LU1280957306.USD","SGXZ99366536.SGD","LU0820561818.USD","LU1267930573.SGD","IE0002270589.USD","LU0820561909.HKD","LU1061106388.HKD","LU2456880835.USD","LU2264538146.SGD","BK4534","LU0266013472.USD","LU0320765992.SGD","LU2552382132.HKD","LU0354030511.USD","LU2461242641.AUD","IE00BJJMRY28.SGD","LU0471298694.HKD","LU1066053197.SGD","LU0234572021.USD","LU0353189763.USD","SG9999015945.SGD","LU0820562030.AUD","SG9999017495.SGD","LU2417539215.USD","SG9999015978.USD","IE00BWXC8680.SGD","LU1868836591.USD","SG9999015986.USD","LU1623119135.USD","LU0823416689.USD","SGXZ81514606.USD","LU2552382058.USD","LU2552382215.SGD","LU2023250504.SGD","LU2596442595.SGD","LU2357305700.SGD","LU0061475181.USD","LU2746668974.SGD","LU0985481810.HKD","LU2168564222.USD","LU2213496289.HKD","LU0094547139.USD","LU1093756168.USD","LU2106854487.HKD","LU2168564149.EUR","LU0310800379.SGD","LU1894683348.USD","IE00BFSS8Q28.SGD","LLY","ELIL","LU2271345857.HKD","LU0683600562.USD","BK4516","LU0006306889.USD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","LU1066051498.USD","LU2237443622.USD","LU0158827781.USD","LU2112291526.USD","LU0708995401.HKD","IE00BJT1NW94.SGD","LU0321505868.SGD","LU0786609619.USD","LU0471298777.SGD","LU0823434583.USD","LU1883839398.USD","LU2089984988.USD","LU1069344957.HKD","LU0225771236.USD","SG9999002224.SGD","LU2111349929.HKD","LU2361045086.USD","IE00BKDWB100.SGD","LU1064131342.USD","LU1974910355.USD","LU1988902786.USD","LU2028103732.USD","LU2746668461.USD","IE00BK4W5M84.HKD","LU2023251221.USD","LU1127390331.HKD","LU0289739699.SGD","LU0109394709.USD","LU0456855351.SGD","LU1093756325.SGD","SGXZ31699556.SGD","SG9999018865.SGD","IE00B4JS1V06.HKD","LU0432979614.USD","IE00BK4W5L77.USD","LU2237443895.HKD","LU0225283273.USD","IE00B1XK9C88.USD","LU0306807586.USD","LU2462157665.USD","SG9999014906.USD","LU0256863811.USD","BK4568","LU0353189680.USD","LU2471134523.USD","LU0672654240.SGD","LU0306806265.USD","LU0868494617.USD","LU1917777945.USD","LU2087625088.SGD","LU1145028129.USD","LU2237443382.USD","LU0210536198.USD","LU0385154629.USD","AZNH","LU0198837287.USD","LU0689472784.USD","LU0417517546.SGD","SG9999013999.USD","LU2491049909.HKD","LU2168564495.EUR","IE00BJLML261.HKD","LU0128525929.USD","IE00B1BXHZ80.USD","LU1868837136.USD","LU0787776722.HKD","LU0109391861.USD","LU0964807845.USD","SG9999001176.SGD","LU0466842654.USD","LU2063271972.USD","LU1548497426.USD","LU2750360997.AUD","IE00BN29S564.USD","LU0058720904.USD","LU2211815571.USD","BK4581","IE00BBT3K403.USD","PFE","LLII","LU0316494557.USD","LU1551013342.USD","LU1868837300.USD","SG9999003800.SGD","LU2468319806.SGD","SG9999014898.SGD","GB00BDT5M118.USD","LU2108987350.USD","LU2471134796.USD","LU2089283258.USD","IE0009355771.USD","BK4550","LU2237438978.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1804176565.USD","LU0323591593.USD","BK4592","LU1323610961.USD","SG9999011175.SGD","SG9999014880.SGD","LU1894683264.USD","LU2168563687.JPY","SGXZ57979304.SGD","LU2089284900.SGD","LU0889565916.HKD","LU0708994859.HKD","BK4588","LU1267930730.SGD","LU1035775433.USD","LU1712237335.SGD","LU0079474960.USD","IE0001KFT4U8.USD","IE0004445015.USD","LU1720051108.HKD","LU0225284248.USD","LU0882574055.USD","LU2750360641.GBP","IE00B7KXQ091.USD","LU0097036916.USD","LU2756315318.SGD","SG9999001176.USD","LU1829250122.USD","LLYX","LU1629891620.HKD","LU0640476718.USD","LU0029864427.USD","LU1720051017.SGD","SG9999014914.USD","SG9999018857.SGD","LU2236285917.USD","LU2360106947.USD","BK4007","BK4533","IE00BFSS7M15.SGD","LU0122379950.USD","LU0882574139.USD","LU2491050071.SGD","LU1023059063.AUD","LU2896262040.SGD","LU2361044949.HKD","LU0170899867.USD","LU1814569148.SGD","IE00BJJMRX11.SGD","LU1868836914.USD","LU0354030438.USD","AZN","LLYZ","IE00B775H168.HKD","LU2471134952.CNY","IE00BLSP4452.SGD","LU2491050154.USD","LU0096364046.USD","LU0321505439.SGD","LU1232071149.USD","IE00B3T34201.USD","LU2602419157.SGD","IE0004445239.USD","LU0158827948.USD","IE00BKPKM429.USD","LU1366192091.USD","BK4585","BK4599","LU2756315664.SGD","IE000M9KFDE8.USD","IE00BJJMRZ35.SGD","IE0005OL40V9.USD","LU2265009873.SGD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643520595","title":"数据简报-全球制药企业斥资数十亿美元以扩大在美国的市场份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2643520595","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643520595?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 20:41","pubTimestamp":1781527269,"startTime":"0","endTime":"0","summary":"路透6月15日 - 全球制药企业正扩大在美国的业务布局，承诺投入数十亿美元以提升该国的生产能力和研发实力。该公司于6月表示，已在佛罗里达州杰克逊维尔市投资约10亿美元，以加强其眼科护理业务在美国本土的制造能力。默克动物保健部门将投资8.95亿美元，用于扩建其位于堪萨斯州的制造和研发基地，这是该公司截至2028年总额达90亿美元的美国投资计划的一部分。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL4T42N15M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","IE000SO60NU8.SGD","IE00BJJMRZ35.SGD","IE00B3T34201.USD","LU1037948541.HKD","LU0133085943.USD","LU0128525929.USD","LU0965509101.SGD","LU0471298694.HKD","BIIB","LU0211331839.USD","LU0980610538.SGD","IE00BFSS8Q28.SGD","LU1623119135.USD","LU2237443549.SGD","LU0353189763.USD","LU1983299246.USD","LU1267930490.SGD","LU1974910355.USD","SGXZ57979304.SGD","IE0002270589.USD","LLY","LU0321505439.SGD","IE0004445015.USD","LU2211815571.USD","LU0456855351.SGD","LU1196500208.SGD","IE0004445239.USD","LU1829250122.USD","LU2125154778.USD","IE00BDGV0183.EUR","LU0823416689.USD","LU1093756325.SGD","LU1989772923.USD","LU2125154935.USD","LU2505996681.GBP","SGXZ51526630.SGD","LU0949170772.SGD","LU1244550494.USD","IE00BLSP4452.SGD","IE00BN29S564.USD","LU1935042991.SGD","IE000F7OJYX1.SGD","LU2491049909.HKD","LU0965509283.SGD","LU0097036916.USD","IE00BVYPNW00.USD","LU2129689514.USD","LU2087625088.SGD","LU2237443465.HKD","IE00B7KXQ091.USD","LU1868836914.USD","IE000MB6IJN5.SGD","LU1035775433.USD","LU0471298777.SGD","LU1934455194.USD","LU2023250330.USD","IE0002141913.USD","LU0158827781.USD","BK4599","LU0792757196.USD","LU2271345857.HKD","IE00BFSS7M15.SGD","LU2087621335.USD","GB00BDT5M118.USD","LU0070302665.USD","LU2750360997.AUD","LU1923622614.USD","SG9999015341.SGD","LU1003077747.HKD","IE00BBT3K403.USD","LU0385154629.USD","LU0345770308.USD","BK7501","LU0345769128.USD","LU0943347566.SGD","LU1043141123.HKD","LU0256863902.USD","LU2168564495.EUR","LU1066053197.SGD","LU2324357040.USD","LU1221951046.USD","LU1571399168.USD","LU2264538146.SGD","LU2471134879.HKD","BK7511","LU2063271972.USD","LU1934455863.HKD","LU0061475181.USD","LU0353189680.USD","IE00BJLML261.HKD","IE0000B7K699.USD","LU0170899867.USD","LU2596442595.SGD","LU0432979614.USD","LU0868494617.USD","IE00BN8TJ469.HKD","IE0009355771.USD","LU1585245621.USD","LU2360106947.USD","LU0070217475.USD","LU2750360641.GBP","LU1670628061.USD","LU2125909247.SGD","SG9999003800.SGD","LU0985481810.HKD","LU0234572021.USD","LU1712237335.SGD","LU0354030438.USD","LU2242646821.SGD","BK4139","LU1430594728.SGD","LU0889565916.HKD","LU2552382058.USD","LU1061106388.HKD","LU0310800379.SGD","SG9999015986.USD","IE00BLSP4239.USD","IE000WAW04H5.SGD","LU1064131342.USD","IE00B1XK9C88.USD","LU2028103732.USD","LU2111349929.HKD","LU2746668974.SGD","LU2471134952.CNY","LU2236285917.USD","LU0942090050.USD","LU1699723380.USD","IE00B775H168.HKD","IE00BSNM7G36.USD","LU0964807845.USD","LU1674673428.USD","LU1201861249.SGD","LU1548497426.USD","IE00BJJMRY28.SGD","LU0823434740.USD","LU0648001328.SGD","LU0321505868.SGD","LU1496350171.SGD","LU1868837136.USD","LU0320765646.SGD","IE00BJJMRX11.SGD","LU1116320737.USD","LU1162221912.USD","LU0114720955.EUR","LU0122379950.USD","LU0208291251.USD","LU0708995401.HKD","LU1989772840.SGD","BK4532","LU2237438978.USD","LU2430703095.HKD","LU0553294199.USD","LU0289961442.SGD","LU0965509010.AUD","LU0210528500.USD","LLYX","LU0106261372.USD","LU0130102774.USD","LU0053666078.USD","LU1032955483.USD","LU0225283273.USD","LU1280957306.USD","LU2756315318.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0320765059.SGD","IE00B894F039.SGD","LU0545562505.USD","SGXZ99366536.SGD","IE000BZT7R73.USD","SG9999015358.SGD","IE0001KFT4U8.USD","LU1839511570.USD","LU0289739699.SGD","LU0320765992.SGD","LU1066051225.USD","LU2456880835.USD","LU0316494557.USD","LU2168564065.EUR","LU0225771236.USD","LU0787776722.HKD","SG9999015978.USD","LU2129689431.USD","SG9999001176.SGD","LU2592432038.USD","BK4585","IE00BK4W5M84.HKD","LU0256863811.USD","LU2552382215.SGD","GILD","BK4588","LU2471134796.USD","LU2360032135.SGD","SG9999014880.SGD","LU1917777945.USD","LU1023059063.AUD","LU2357627491.SGD","LU0689472784.USD","IE00B4R5TH58.HKD","LU2237443978.SGD","LU1145028129.USD","JNJ","LU0203202063.USD","ELIS","AMGN","LU0098860793.USD","LU2491050154.USD","LU1267930813.SGD","SG9999018865.SGD","LU0211328371.USD","LU0345769631.USD","BK4516","BK4550","LU2023251221.USD","LU0417517546.SGD","LU0323591593.USD","LU1894683264.USD","LU1496350502.SGD","LU0683600562.USD","LU0889566641.SGD","LU2125909593.SGD","LU2265009873.SGD","LU2746668461.USD","LU0672654240.SGD","SG9999018857.SGD","LU1629891620.HKD","IE00B19Z3581.USD","LU2133065610.SGD","LU1232071149.USD","LU2089283258.USD","IE00B1BXHZ80.USD","LU0426417589.USD","LU0823434583.USD","AZN","LU0466842654.USD","LU0225284248.USD","IE00B42XCP33.USD","LU2417539215.USD","LU0265550359.USD","IE00BJT1NW94.SGD","SG9999002224.SGD","LU0965508806.USD","LU0511384066.AUD","LU1804176565.USD","LU0029864427.USD","LU2108987350.USD","LU0203345920.USD","BK4533","LU0861579265.USD","LU2237443895.HKD","LU0079474960.USD","SG9999015945.SGD","LU0094547139.USD","BK4007","LLII","LU1267930730.SGD","LU2347655156.SGD","LU2430703178.SGD","LU1032466523.USD","SG9999013999.USD","SG9999001440.SGD","IE00B2B36J28.USD","IE00BK4W5L77.USD","LU2602419157.SGD","LU2461242641.AUD","LU2361044949.HKD","IE00BFTCPJ56.SGD","LU0211327993.USD","LU1929549753.HKD","LU1267930573.SGD","LU0069063385.USD","LU2491050071.SGD","LU1221951129.SGD","LU1720051108.HKD","LU0426412945.USD","GSKH","LU1989771016.USD","IE00B7SZLL34.SGD","LU0234570918.USD","LU2023250843.SGD","LU0882574139.USD","LU0708994859.HKD","LU0130517989.USD","LU0354030511.USD","LU2487616109.SGD","LU0738911758.USD","LU1883839398.USD","LU0198837287.USD","LU1941712348.USD","LU0109394709.USD","LU1732799900.SGD","LU0310799852.SGD","LU1732800096.USD","SG9999014914.USD","SG9999001176.USD","LLYZ","LU1868836591.USD","SG9999014898.SGD","SG9999017495.SGD","SG9999014567.USD","LU1074936037.SGD","LU1914381329.SGD","LU0266013472.USD","LU0859254822.USD","LU1066051811.HKD","AZNH","LU2106854487.HKD","BK4581","LU2112291526.USD","LU1093756168.USD","IE00BKDWB100.SGD","LU0058720904.USD","LU0306807586.USD","LU1057294990.SGD","LU0820561818.USD","IE00BVYPNV92.GBP","LU2023250504.SGD","LU0868494708.USD","LU1720051017.SGD","LU2089284900.SGD","LU1551013425.SGD","LU1127390331.HKD","LU2433249047.HKD","BK4592","LU0472753341.HKD","LU1778281490.HKD","LU2168564149.EUR","SG9999014906.USD","SG9999015952.SGD","LU2213496289.HKD","LU0306806265.USD","LU2462157665.USD","LU1043141396.HKD","LU1121112475.USD","SG9999014559.SGD","LU0820562030.AUD","LU0124676726.USD","LU0265550946.USD","IE00B19Z3B42.SGD","LU0320765489.SGD","LU1035773651.USD","LU0057025933.USD","BK4559","LU0109391861.USD","LU1059921491.USD","LU0994945656.USD","LU0661504455.SGD","LU0238689110.USD","LU0912757837.SGD","LU0158827948.USD","CSL.AU","LU1894683348.USD","LU1988902786.USD","SG9999002232.USD","LU1366192091.USD","LU2361045086.USD","LU2237443622.USD","IE00BWXC8680.SGD","IE00B19Z9P08.USD","LU1814569148.SGD","LU1934455277.USD","LU0345770993.USD","LU0096364046.USD","LU1037948897.HKD","LU0795875086.SGD","LU0640476718.USD","SG9999014542.SGD","LU1069344957.HKD","LU1941712264.USD","LU2756315664.SGD","LU1244550221.USD","IE00BGHQF631.EUR","BK4568","LU1868836757.USD","BK4578","LU2168563687.JPY","BK7508","SG9999014575.USD","LU2552382132.HKD","LU1291159041.SGD","LU0210536198.USD","PFE","LU0882574055.USD","SGXZ81514606.USD","MRK","LU2089984988.USD","LU1066051498.USD","LU2896262040.SGD","IE00BKPKM429.USD","LU1718418525.SGD","LU2129689605.HKD","LU1670627923.USD","LU0477156953.USD","GSK.UK","LU2468319806.SGD","BK4534","BK4583","LU1868837300.USD","LU0786609619.USD","LU1674673691.USD","IE00BFXG1179.USD","IE0034235303.USD","LU0689626769.HKD","LU2168564222.USD","LU2471134523.USD","LU1261432733.SGD","LU0985320562.USD","LU2237443382.USD","LU2403377893.USD","LU2505996509.AUD","BK4566","LU1551013342.USD","LU0006306889.USD","BK4504","LU0545039389.USD","IE0005OL40V9.USD","SG9999011175.SGD","ELIL","LU0203201768.USD","IE000M9KFDE8.USD","LU1069347547.HKD","LU1244550577.SGD","LU0289739343.SGD","LU0795875169.SGD","SGXZ31699556.SGD","LU0820561909.HKD","LU1228905037.USD","ABBV","LU2430703251.USD","LU1228905540.USD","LU0203347892.USD","LU2361044865.SGD","IE00B19Z9Z06.USD","04332","IE00B4JS1V06.HKD","LU1323610961.USD","LU1506573853.SGD","BK7067","LU1116320901.HKD","IE00B3PB1722.GBP","LU2357305700.SGD","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642189402","title":"重返肿瘤核心战场 葛兰素史克(GSK.US)能否借Nuvalent缩小与阿斯利康差距？","url":"https://stock-news.laohu8.com/highlight/detail?id=2642189402","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642189402?lang=zh_cn&edition=fundamental","pubTime":"2026-06-11 15:56","pubTimestamp":1781164594,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，葛兰素史克以创纪录的106亿美元收购美国生物技术公司Nuvalent，此举将加快这家英国制药巨头旗下抗癌药物业务的重建步伐，以应对来自更大竞争对手阿斯利康和罗氏的竞争压力。米尔斯在周二宣布收购Nuvalent后对记者表示。葛兰素史克并不打算在全部肿瘤领域与默沙东、阿斯利康或罗氏正面竞争，但将其视为潜在的增长领域。收购Nuvalent将为葛兰素史克产品组合增添两款晚期药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["GSK","GSK.UK","NUVL","LU2237443549.SGD","AZN","BK4585","BK4588","BK4007","LU2237443895.HKD","LU0889565916.HKD","IE00B3T34201.USD","LU2237443382.USD","LU0109394709.USD","LU2417539215.USD","LU2237443978.SGD","LU2237443622.USD","AZNH","BK4568","LU2237443465.HKD","BK4539","BK4532","BK4139","LU2456880835.USD","LU0289739699.SGD","LU0320765992.SGD","LU1829250122.USD","LU2462157665.USD","GSKH","LU0058720904.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642452868","title":"阿斯利康加入减肥药赛道：口服药减重11.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642452868","media":"华尔街见闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642452868?lang=zh_cn&edition=fundamental","pubTime":"2026-06-09 14:19","pubTimestamp":1780985960,"startTime":"0","endTime":"0","summary":"阿斯利康的口服减肥药elecoglipron二期数据亮眼，36周内减重11.8%。虽效果略逊于礼来，但5%的副作用退出率远低于礼来的17%，且无需空腹。目前该药已进三期，正推进与心肾药联合开发以形成差异化竞争。","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3774191","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443895.HKD","LU0889565916.HKD","BK4588","LU2462157665.USD","BK4568","LU2237443549.SGD","LU2237443978.SGD","LU2237443382.USD","LU2237443465.HKD","AZNH","LU1829250122.USD","LU2237443622.USD","LU2236285917.USD","BK4007","LU0058720904.USD","LU2456880835.USD","LU0320765992.SGD","AZN","IE00B3T34201.USD","LU0289739699.SGD","BK4585","LU0109394709.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1163381786","title":"阿斯利康GLP-1口服药在糖尿病与肥胖症试验中通过早期考验","url":"https://stock-news.laohu8.com/highlight/detail?id=1163381786","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163381786?lang=zh_cn&edition=fundamental","pubTime":"2026-06-09 06:27","pubTimestamp":1780957629,"startTime":"0","endTime":"0","summary":"根据周一在美国糖尿病协会年度会议上公布的二期试验结果，阿斯利康的实验性GLP-1口服药在为期36周的治疗中，使肥胖患者的体重平均降低了近12%。同时，该药物将糖尿病患者的糖化血红蛋白水平——一项衡量血糖的关键指标——平均降低了1.9个百分点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU2456880835.USD","LU2237443895.HKD","LU1829250122.USD","LU2462157665.USD","BK4585","BK4007","LU2237443978.SGD","AZN","BK4144","AZNH","LU2237443622.USD","LU0289739699.SGD","BK4590","LU2237443465.HKD","LU0109394709.USD","IE00B3T34201.USD","LU0889565916.HKD","LU2417539215.USD","LU2236285917.USD","LU2237443382.USD","BK4588","BK4568","GLP","LU0320765992.SGD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641169538","title":"数据简报-邦迪布吉奥埃博拉：疫苗与疗法研发一览","url":"https://stock-news.laohu8.com/highlight/detail?id=2641169538","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641169538?lang=zh_cn&edition=fundamental","pubTime":"2026-06-05 00:29","pubTimestamp":1780590599,"startTime":"0","endTime":"0","summary":"数据简报-邦迪布吉奥埃博拉：疫苗与疗法研发一览在第42和43段中补充了关于罗氏检测的细节Mariam Sunny/Jennifer Rigby. 与更常见的扎伊尔毒株不同，目前尚无针对邦迪布吉奥毒株的获批疫苗或治疗方法。邦迪布吉奥埃博拉病毒的致死率高达40%。CEPI表示，将初步投资高达860万美元用于该疫苗的研发。该药物最初针对苏丹埃博拉病毒株进行研究，在早期试验中被证实安全且耐受性良好。据该公司称，实验室研究显示该药物对邦迪布吉奥埃博拉病毒具有活性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nL4T42C1HI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","REGN","LU0114720955.EUR","LU0823434740.USD","LU1934455194.USD","IE000M9KFDE8.USD","SG9999001440.SGD","LU2362540622.SGD","LU1093756168.USD","LU1674673428.USD","LU0053666078.USD","IE00B19Z3B42.SGD","LU1941712348.USD","IE00BN8TJ469.HKD","LU0058720904.USD","LU2237443622.USD","LU1061106388.HKD","SG9999013999.USD","LU2361044865.SGD","LU0266013472.USD","LU1066051498.USD","MRNY","LU0265550359.USD","LU0070302665.USD","SGXZ57979304.SGD","LU0006306889.USD","BK4568","LU1069347547.HKD","LU2237443465.HKD","LU2433249047.HKD","LU1162221912.USD","LU1934455277.USD","LU0238689110.USD","IE00BSNM7G36.USD","LU1778281490.HKD","GILD","LU0648001328.SGD","BK4588","LU1929549753.HKD","LU2461242641.AUD","MRNX","LU0289739699.SGD","LU2357627491.SGD","LU0109394709.USD","LU2125909247.SGD","LU0130517989.USD","LU0965509010.AUD","LU1201861249.SGD","RHHBY","SG9999015978.USD","LU2237438978.USD","SG9999001176.USD","IE00BBT3K403.USD","IE00B4R5TH58.HKD","SG9999014542.SGD","IE00B19Z3581.USD","LU0203347892.USD","LU0432979614.USD","LU1571399168.USD","MRK","LU0859254822.USD","LU0130102774.USD","LU1066051225.USD","LU0211331839.USD","LU0106261372.USD","AZN","BK4532","IE00BJJMRZ35.SGD","LU0882574055.USD","LU1057294990.SGD","LU0234570918.USD","LU1037948541.HKD","LU2023250843.SGD","LU2360032135.SGD","LU1989772840.SGD","LU2089984988.USD","LU2106854487.HKD","SG9999015986.USD","LU1035773651.USD","LU1934455863.HKD","LU0477156953.USD","LU0985320562.USD","LU2362541513.USD","AZNH","MRNA","03165","LU2087621335.USD","BK4585","LU0868494617.USD","LU1430594728.SGD","LU2236285917.USD","LU1585245621.USD","LU0208291251.USD","LU1923622614.USD","LU2417539215.USD","SG9999014575.USD","LU2361044949.HKD","LU0823434583.USD","LU1023059063.AUD","LU0965509101.SGD","LU2462157665.USD","LU0203345920.USD","LU2125154935.USD","BK4550","SG9999015945.SGD","LU1699723380.USD","SG9999015341.SGD","LU0889565916.HKD","LU1989772923.USD","BK4534","LU0265550946.USD","LU0320765992.SGD","LU1116320737.USD","LU0965509283.SGD","BK4583","LU2491050071.SGD","LU0965508806.USD","LU2125909593.SGD","LU0098860793.USD","LU1291159041.SGD","IE0009355771.USD","LU1941712264.USD","IE00B1BXHZ80.USD","LU1974910355.USD","SG9999014567.USD","LU2491050154.USD","LU1674673691.USD","LU1983299246.USD","LU2324357040.USD","IE00BLSP4452.SGD","LU2237443549.SGD","LU2491049909.HKD","LU0823416689.USD","IE00B3T34201.USD","LU2456880835.USD","LU1989771016.USD","LU1917777945.USD","LU2023250504.SGD","LU1829250122.USD","LU0942090050.USD","LU0868494708.USD","LU2468319806.SGD","SG9999015358.SGD","LU0320765646.SGD","LU2361045086.USD","LU2112291526.USD","BK4548","BK4578","SG9999001176.SGD","BK4516","LU2237443895.HKD","IE00BKVL7J92.USD","LU2362541273.HKD","SG9999002224.SGD","BK4566","BK4139","LU1066053197.SGD","LU0861579265.USD","IE00B2B36J28.USD","BK4007","IE00BJT1NW94.SGD","LU2237443978.SGD","LU1116320901.HKD","IE0002141913.USD","LU0122379950.USD","BK4533","LU1839511570.USD","IE0002270589.USD","IE00BLSP4239.USD","IE00B7SZLL34.SGD","SG9999014559.SGD","LU0234572021.USD","SG9999002232.USD","SG9999015952.SGD","BK4559","IE00BFTCPJ56.SGD","IE00BZ1G4Q59.USD","LU0320765489.SGD","LU1093756325.SGD","LU1037948897.HKD","BK4551","LU2125154778.USD","LU1066051811.HKD","BK4501","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640596407","title":"阿斯利康(AZN)股票6月1日收盘下跌3.17%：关键驱动因素揭晓","url":"https://stock-news.laohu8.com/highlight/detail?id=2640596407","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640596407?lang=zh_cn&edition=fundamental","pubTime":"2026-06-02 04:15","pubTimestamp":1780344918,"startTime":"0","endTime":"0","summary":"• Anselamimab 治疗轻链型淀粉样变性的试验未达到主要终点。\n• FDA 延长了乳腺癌疗法 camizestrant 的审查期限。\n• 积极的试验结果和分析师评级未能抵消挫折带来的影响。","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/261939880-market-movers-azn-20260601","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","LU0889565916.HKD","LU2417539215.USD","LU0289739699.SGD","AZN","BK4588","LU0109394709.USD","BK4568","AZNH","LU2237443549.SGD","BK4585","LU2456880835.USD","LU1829250122.USD","LU2237443978.SGD","IE00B3T34201.USD","LU2237443465.HKD","LU2462157665.USD","LU2237443622.USD","LU2237443895.HKD","LU0058720904.USD","BK4007","LU0320765992.SGD","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640895351","title":"数据简报-正在研发哪些邦迪布吉奥型埃博拉疫苗和治疗方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2640895351","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640895351?lang=zh_cn&edition=fundamental","pubTime":"2026-06-01 18:27","pubTimestamp":1780309661,"startTime":"0","endTime":"0","summary":"数据简报-正在研发哪些邦迪布吉奥型埃博拉疫苗和治疗方法在第13、17和21段中补充了关于CEPI资金及Moderna候选疫苗的详情Mariam Sunny/Jennifer Rigby. 路透6月1日 - 全球卫生部门正争分夺秒地寻找医疗方案，以遏制刚果民主共和国东部与邦迪布吉奥埃博拉病毒毒株相关的疫情。与更常见的扎伊尔毒株不同，目前尚无针对邦迪布吉奥毒株的获批疫苗或治疗方法。邦迪布吉奥埃博拉病毒的致死率高达40%。据该公司称，实验室研究显示该药物对邦迪布吉奥埃博拉病毒具有活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nL4S4290QF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2433249047.HKD","SG9999001176.USD","LU0130517989.USD","LU1989772840.SGD","LU2106854487.HKD","LU2361045086.USD","LU2461242641.AUD","IE0002141913.USD","LU0098860793.USD","IE00B19Z3B42.SGD","LU0477156953.USD","LU0648001328.SGD","LU2324357040.USD","BK4583","LU0289739699.SGD","SG9999015341.SGD","REGN","LU0868494708.USD","LU1974910355.USD","LU0006306889.USD","LU0203345920.USD","MRK","IE00BN8TJ469.HKD","LU1699723380.USD","SG9999015358.SGD","LU0211331839.USD","LU1037948541.HKD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0053666078.USD","BK4534","LU0238689110.USD","LU2362541273.HKD","IE00BBT3K403.USD","LU1585245621.USD","LU1291159041.SGD","BK4548","LU0889565916.HKD","IE00BLSP4452.SGD","LU1829250122.USD","BK4568","IE00BFTCPJ56.SGD","LU1066051811.HKD","LU1989771016.USD","LU2360032135.SGD","IE0002270589.USD","IE00B1BXHZ80.USD","LU1983299246.USD","LU2362541513.USD","LU0965509283.SGD","AZN","LU2237438978.USD","SG9999013999.USD","LU0234572021.USD","LU2125154778.USD","IE00BJT1NW94.SGD","LU2491049909.HKD","BK4578","SG9999015945.SGD","SG9999001176.SGD","BK4533","LU1674673691.USD","MRNA","LU0265550359.USD","LU1941712348.USD","LU1674673428.USD","LU1839511570.USD","LU2362540622.SGD","SG9999015986.USD","LU1778281490.HKD","LU0985320562.USD","LU2468319806.SGD","LU0265550946.USD","LU0203347892.USD","IE00BSNM7G36.USD","AZNH","LU0882574055.USD","SG9999015952.SGD","LU0965509010.AUD","IE00B3T34201.USD","LU1037948897.HKD","LU0109394709.USD","LU1093756168.USD","BK4007","BK4139","LU0070302665.USD","LU1116320901.HKD","LU1066051225.USD","LU1934455277.USD","LU1917777945.USD","LU2237443622.USD","LU2417539215.USD","LU0861579265.USD","IE00B4R5TH58.HKD","LU1066053197.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","LU1923622614.USD","SG9999014542.SGD","BK4532","LU2357627491.SGD","LU0859254822.USD","LU0114720955.EUR","LU0823416689.USD","LU1066051498.USD","LU1093756325.SGD","LU0965509101.SGD","IE00BLSP4239.USD","IE00BZ1G4Q59.USD","LU2491050154.USD","MRNY","LU0234570918.USD","LU0320765992.SGD","LU2236285917.USD","BK4585","LU1941712264.USD","LU2112291526.USD","LU2237443978.SGD","IE00B2B36J28.USD","LU0106261372.USD","LU0965508806.USD","BK4550","LU2125154935.USD","BK4551","LU1116320737.USD","IE00B19Z3581.USD","LU1430594728.SGD","SG9999014575.USD","LU2087621335.USD","LU0266013472.USD","LU1069347547.HKD","LU2491050071.SGD","SG9999001440.SGD","SG9999002224.SGD","SG9999014559.SGD","LU2125909247.SGD","LU2361044949.HKD","GILD","LU0942090050.USD","BK4516","SG9999014567.USD","LU2125909593.SGD","IE00B7SZLL34.SGD","BK4559","LU2462157665.USD","LU0058720904.USD","LU1934455194.USD","LU1989772923.USD","LU1162221912.USD","SG9999002232.USD","BK4588","LU2237443895.HKD","BK4566","LU0320765646.SGD","LU2023250843.SGD","LU2456880835.USD","IE0009355771.USD","IE00BKVL7J92.USD","SGXZ57979304.SGD","SG9999015978.USD","LU2237443549.SGD","MRNX","LU1023059063.AUD","LU2089984988.USD","LU1201861249.SGD","LU0823434583.USD","BK4501","LU1035773651.USD","LU0432979614.USD","LU1571399168.USD","LU0122379950.USD","LU0980610538.SGD","LU2237443382.USD","LU0320765489.SGD","LU2237443465.HKD","LU2361044865.SGD","LU1929549753.HKD","LU0823434740.USD","LU1934455863.HKD","LU2023250504.SGD","LU0208291251.USD","LU0130102774.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639256620","title":"阿斯利康(AZN.US)本瑞利珠单抗新适应症获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2639256620","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639256620?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 21:10","pubTimestamp":1780060236,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月29日，NMPA官网显示，阿斯利康本瑞利珠单抗一项新适应症获批上市，用于治疗成人和 12 岁及以上青少年患者无明确非血液学继发性病因的嗜酸性粒细胞增多综合征。在国际多中心 III 期 NATRON 临床试验中，阿斯利康评估了本瑞利珠单抗治疗 HES 患者的有效性和安全性，试验的主要研究终点为患者至首次恶化或复发的时间。研究结果显示，与安慰剂相比，本瑞利珠单抗显著延缓了患者首次 HES 发作的时间，发作风险降低 65%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443549.SGD","LU0320765992.SGD","LU2236285917.USD","AZN","LU2237443465.HKD","LU2456880835.USD","BK4007","LU0889565916.HKD","BK4585","BK4568","IPOS","LU2237443382.USD","LU2237443622.USD","AZNH","LU0058720904.USD","LU2237443978.SGD","LU2462157665.USD","BK4588","LU0289739699.SGD","IE00B3T34201.USD","LU2237443895.HKD","LU2417539215.USD","LU0109394709.USD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639627307","title":"石药集团(01093)：收到阿斯利康就创新长效多肽药物开发的战略合作与授权协议项下的12亿美元首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2639627307","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639627307?lang=zh_cn&edition=fundamental","pubTime":"2026-05-29 20:19","pubTimestamp":1780057161,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)发布公告，内容有关集团与阿斯利康签订战略研发合作与授权协议(该协议)。集团与阿斯利康签订该协议，以利用集团所拥有的长效递送技术平台及多肽药物AI发现平台，开发创新长效多肽药物，并将根据该协议条款(其中包括)收取12亿美元的首付款。董事会欣然宣布，集团已于2026年5月29日(交易时间后)收到上述阿斯利康支付的首付款12亿美元。该首付款的收取将为集团的财务状况带来正面贡献。目前，双方的合作进展顺利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0501845795.SGD","BK1521","LU1008478684.HKD","LU1328277881.USD","LU2456880835.USD","IE00B031HY20.USD","IE0008368742.USD","BK1191","LU1226288253.USD","LU2039709279.SGD","LU1226287875.USD","IE00BZ08YS42.EUR","LU0880133367.SGD","IE00BZ08YR35.GBP","BK4007","LU2462157665.USD","LU0315179316.USD","LU1829250122.USD","LU1226287529.USD","LU2236285917.USD","LU2237443622.USD","LU2237443465.HKD","LU0109394709.USD","BK4585","LU0058720904.USD","LU0072913022.USD","LU1226287792.SGD","01093","LU2417539215.USD","LU0326950275.SGD","LU0889565916.HKD","LU1960683339.HKD","LU0067412154.USD","LU2237443895.HKD","LU1152091168.USD","LU1152091754.HKD","LU1226288170.HKD","BK1515","LU0140636845.USD","AZN","LU1813983027.USD","LU0314109678.HKD","AZNH","LU1807302812.USD","LU2237443382.USD","BK4588","LU0289739699.SGD","IE0008369823.USD","LU2237443978.SGD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638653068","title":"阿斯利康来无锡深化对接合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2638653068","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638653068?lang=zh_cn&edition=fundamental","pubTime":"2026-05-28 09:49","pubTimestamp":1779932977,"startTime":"0","endTime":"0","summary":"【阿斯利康来无锡深化对接合作】5月27日，无锡市委书记杜小刚与来锡深化对接合作的阿斯利康全球执行副总裁、国际业务负责人尹思睿一行会谈，双方就抓紧落实今年3月省委、省政府主要领导会见阿斯利康全球首席执行官苏博科等高层时商定的深化合作事项进行深入交流。双方在会谈中表示，将牢牢把握江苏省委、省政府与阿斯利康共同确定的深化合作方向，立足无锡与阿斯利康多年合作形成的深厚情谊，推动前期议定的合作事项全面落实、尽快落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605283752295069.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283752295069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["AZN","BK4588","AZNH","LU2237443622.USD","LU0109394709.USD","BK4585","LU1829250122.USD","LU2417539215.USD","LU2237443978.SGD","LU0320765992.SGD","LU2237443895.HKD","BK4568","LU2237443465.HKD","LU0889565916.HKD","LU2456880835.USD","BK4007","LU2237443382.USD","LU0289739699.SGD","LU2462157665.USD","IE00B3T34201.USD","LU0058720904.USD","LU2236285917.USD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637344840","title":"数据简报-邦迪布吉奥埃博拉疫苗和治疗方法正在研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2637344840","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637344840?lang=zh_cn&edition=fundamental","pubTime":"2026-05-23 04:14","pubTimestamp":1779480844,"startTime":"0","endTime":"0","summary":"数据简报-邦迪布吉奥埃博拉疫苗和治疗方法正在研发在第21、23段中补充了Regeneron的评论Mariam Sunny/Jennifer Rigby. 路透5月22日 - 全球卫生部门正争分夺秒地寻找医疗方案，以遏制刚果民主共和国东部与邦迪布吉奥毒株相关的埃博拉疫情。与更为常见的扎伊尔毒株不同，目前尚无针对邦迪布吉奥毒株的获批疫苗或治疗方案。世卫组织表示，生产rVSV邦迪布吉奥疫苗可能需要六到九个月的时间。据该公司称，实验室研究显示该药物对邦迪布吉奥埃博拉病毒具有活性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nL4T41Z1LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360032135.SGD","LU0965509010.AUD","SG9999001440.SGD","LU0823416689.USD","SG9999002232.USD","LU1093756325.SGD","BK4566","LU1934455863.HKD","LU1934455194.USD","IE00BLSP4452.SGD","SG9999015952.SGD","LU2237438978.USD","BK4550","LU2357627491.SGD","LU2023250504.SGD","LU2023250843.SGD","SG9999014559.SGD","IE00BJT1NW94.SGD","BK4007","IE00BKVL7J92.USD","SG9999015358.SGD","BK4585","SG9999015978.USD","LU1057294990.SGD","LU2237443895.HKD","LU0882574055.USD","LU1066051498.USD","LU2461242641.AUD","LU0980610538.SGD","LU2361044865.SGD","AZN","SGXZ57979304.SGD","LU1066051225.USD","MRK","LU2237443978.SGD","LU1066051811.HKD","LU0114720955.EUR","LU1093756168.USD","SG9999014567.USD","IE000M9KFDE8.USD","SG9999015341.SGD","SG9999014542.SGD","LU1839511570.USD","BK4533","IE00B4R5TH58.HKD","LU0265550946.USD","LU1061106388.HKD","LU0109394709.USD","LU0053666078.USD","LU0320765992.SGD","LU0432979614.USD","SG9999002224.SGD","IE00BN8TJ469.HKD","LU1934455277.USD","LU1989772923.USD","LU0965509283.SGD","LU0889565916.HKD","LU0130517989.USD","IE00B19Z3B42.SGD","LU0203345920.USD","LU0106261372.USD","LU2462157665.USD","BK4139","LU1069347547.HKD","LU2237443549.SGD","LU0648001328.SGD","LU1989771016.USD","LU0122379950.USD","LU0211331839.USD","LU2324357040.USD","IE00BZ1G4Q59.USD","IE00BFTCPJ56.SGD","IE00B3T34201.USD","IE00B7SZLL34.SGD","SG9999015945.SGD","LU2491050154.USD","LU2125909593.SGD","LU0965508806.USD","LU2491049909.HKD","LU0289739699.SGD","BK4583","LU0320765646.SGD","SG9999001176.SGD","LU2089984988.USD","LU2362541513.USD","BK4568","LU0265550359.USD","LU1941712264.USD","LU2362540622.SGD","LU0868494617.USD","LU1778281490.HKD","LU1829250122.USD","LU0208291251.USD","LU1116320737.USD","LU1923622614.USD","LU2491050071.SGD","LU0477156953.USD","LU1116320901.HKD","LU1035773651.USD","LU1674673428.USD","LU1674673691.USD","LU1430594728.SGD","LU1941712348.USD","IE00BLSP4239.USD","LU0868494708.USD","IE00BJJMRZ35.SGD","LU1037948541.HKD","LU2456880835.USD","IE00BBT3K403.USD","LU2112291526.USD","BK4534","LU2236285917.USD","LU2468319806.SGD","LU1201861249.SGD","IE0009355771.USD","LU0234572021.USD","AZNH","LU2237443382.USD","IE00B19Z3581.USD","BK4532","LU0203347892.USD","LU1929549753.HKD","LU2361045086.USD","LU0006306889.USD","LU2125154778.USD","LU0238689110.USD","LU1585245621.USD","BK4588","GILD","IE00B2B36J28.USD","BK4578","LU2237443622.USD","LU2417539215.USD","LU2361044949.HKD","LU2362541273.HKD","LU1699723380.USD","LU1162221912.USD","IE00B1BXHZ80.USD","LU1571399168.USD","BK4559","REGN","IE00BSNM7G36.USD","LU0098860793.USD","LU1917777945.USD","LU2125154935.USD","LU0965509101.SGD","LU0070302665.USD","BK4516","LU0942090050.USD","IE0002141913.USD","SG9999014575.USD","LU2433249047.HKD","IE0002270589.USD","LU2106854487.HKD","LU1983299246.USD","LU0266013472.USD","LU2125909247.SGD","LU1066053197.SGD","LU1291159041.SGD","LU0823434740.USD","LU2087621335.USD","SG9999001176.USD","LU0234570918.USD","LU1974910355.USD","LU0058720904.USD","LU1023059063.AUD","LU1037948897.HKD","SG9999015986.USD","LU0823434583.USD","LU1989772840.SGD","LU0985320562.USD","LU0861579265.USD","LU0130102774.USD","LU0859254822.USD","SG9999013999.USD","LU2237443465.HKD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":8,"totalSize":177,"code":"91000000","status":"200"}]}}